A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

NCT07542704 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Colorectal Cancer (CRC)
Non-Small Cell Lung Cancer
Uterine Cancer
KRAS G12C Mutations
KRAS G12S Mutations

Interventions

DRUG: KQB368

Sponsor

Kumquat Biosciences Inc.

Collaborators

[object Object]